Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Change in Acquisitions & Divestments: 2009-2025

Historic Change in Acquisitions & Divestments for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Sep 2025 value amounting to $596.0 million.

  • UNITED THERAPEUTICS's Change in Acquisitions & Divestments rose 162.32% to $596.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 billion, marking a year-over-year increase of 17.37%. This contributed to the annual value of $1.5 billion for FY2024, which is 28.09% down from last year.
  • According to the latest figures from Q3 2025, UNITED THERAPEUTICS's Change in Acquisitions & Divestments is $596.0 million, which was down 8.85% from $653.9 million recorded in Q2 2025.
  • Over the past 5 years, UNITED THERAPEUTICS's Change in Acquisitions & Divestments peaked at $831.8 million during Q1 2024, and registered a low of $131.9 million during Q1 2022.
  • Over the past 3 years, UNITED THERAPEUTICS's median Change in Acquisitions & Divestments value was $561.4 million (recorded in 2023), while the average stood at $553.6 million.
  • Per our database at Business Quant, UNITED THERAPEUTICS's Change in Acquisitions & Divestments crashed by 70.97% in 2022 and then soared by 438.06% in 2023.
  • UNITED THERAPEUTICS's Change in Acquisitions & Divestments (Quarterly) stood at $366.6 million in 2021, then fell by 26.73% to $268.6 million in 2022, then spiked by 96.09% to $526.7 million in 2023, then fell by 9.25% to $478.0 million in 2024, then skyrocketed by 162.32% to $596.0 million in 2025.
  • Its last three reported values are $596.0 million in Q3 2025, $653.9 million for Q2 2025, and $611.7 million during Q1 2025.